article thumbnail

Top FDA Vaccine Official Quits, Warns of Vaccine Misinformation

Drugs.com

MONDAY, March 31, 2025 -- A top vaccine official at the U.S. Food and Drug Administration (FDA) is stepping down, warning that vaccine misinformation is coloring the countrys top health decisions.Dr. Peter Marks, director of the FDAs Center for Bi.

Vaccine 273
article thumbnail

Paxlovid May Offer Little Benefit for Vaccinated Older Adults

Drugs.com

THURSDAY, March 6, 2025 -- The antiviral drug Paxlovid may not offer much protection against COVID-related hospitalizations or deaths for vaccinated older adults after all. Research published recently in JAMA Network Open looked at data from more.

Vaccine 343
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

'Low-sugar' vaccine can provide broad immunity against coronavirus variants

Science Daily: Pharmacology News

Early animal studies show that a single vaccine could protect the recipient from different variants of the coronaviruses that cause COVID-19, the flu and the common cold.

Vaccine 301
article thumbnail

Bacterial vaccine shows promise as cancer immunotherapy

Science Daily: Pharmacology News

Researchers have engineered bacteria as personalized cancer vaccines that activate the immune system to specifically seek out and destroy cancer cells.

Vaccine 331
article thumbnail

NIH Cuts Funding for Studies on Vaccine Hesitancy and Acceptance

Drugs.com

TUESDAY, March 11, 2025 -- The National Institutes of Health (NIH) is cutting or canceling more than 40 grants focused on vaccine hesitancy and ways to increase vaccine acceptance, according to an email obtained by The Washington Post.The message .

Vaccine 278
article thumbnail

New mRNA vaccine created to prevent and treat C. difficile

Science Daily: Pharmacology News

A new vaccine provides hope for treating and even preventing the highly contagious and difficult-to-treat Clostridioides difficile infection, more commonly known as C. difficile vaccine was found to protect against C. difficile vaccine was found to protect against C. difficile or C. In animal models, this first mRNA-LNP C.

Vaccine 312
article thumbnail

Researchers confront new US and global challenges in vaccinations of adults

Science Daily: Pharmacology News

Over the past decade, decreasing vaccination rates now threaten the huge beneficial impacts of vaccinations in the U.S. Researchers discuss the multifactorial barriers including increasing vaccine hesitancy and new clinical and public health challenges in vaccinations of U.S. and globally.

Vaccine 306